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Abstract
Both imprinting and maternal effects could lead to parent-of-origin patterns in complex traits of
human disorders. Statistical methods that differentiate these two effects and identify them
simultaneously by using family-based data from retrospective studies are available. The usual data
structures include case-parents triads and nuclear families with multiple affected siblings. We
develop a likelihood-based method to detect imprinting and maternal effects simultaneously using
data from prospective studies. The proposed method utilizes both affected and unaffected siblings
in nuclear families by modeling familial genotypes and offspring’s disease status jointly. Maternal
effect is usually modeled as a fixed effect under the assumption that maternal variant allele(s) has
(have) identical effect on any offspring. However, recent studies report that different people may
carry different amounts of substances encoded by the mother’s variant allele(s) (called maternal
microchimerism), which could result in heterogeneity of maternal effects. The proposed method
incorporates the heterogeneity of maternal effects by adding a random component to the logit of
the penetrance. Our method was applied to the Framingham Heart Study data in two steps to
detect single-nucleotide polymorphisms (SNPs) that may be associated with high blood pressure. In
the first step, SNPs that affect susceptibility of high blood pressure through minor allele, genomic
imprinting, or maternal effects were identified by using the proposed model without the random
effect component. In the second step, we fitted the mixed effect model to the identified SNPs that
have significant maternal effect to detect heterogeneity of the maternal effects.
Background
The phenomenon that a trait follows a maternal or
paternal lineage, instead of following the mendelian
mode of inheritance, is referred to as the parent-of-origin
pattern. Genomic imprinting and maternal effect could
give rise to similar parent-of-origin patterns [1]. Hence,
models, which are designed to identify genomic imprint-
ing by detecting the parent-of-origin pattern, may report
false positives that are actually due to maternal effect.
A log-linear likelihood-ratio test (LL-LRT) [2,3] was
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simultaneously by using case-parents triads. This
approach was then extended to the parent-of-origin
likelihood ratio test (PO-LRT) to detect imprinting and
maternal effects at a marker that is in linkage disequili-
brium with a candidate gene [4].
A case-parents triad could have 15 possible familial
genotype combinations [2-4]. LL-LRT and PO-LRT model
the counts of the 15 categories by using log-linear and
logistic regression, respectively. It has been shown that
these methods are robust for detecting imprinting effect
even in the presence of maternal effect. However, when
multiple affected siblings are genotyped (e.g., the North
American Rheumatoid Arthritis Consortium data set
[5]), trimming nuclear families to case-parents triads
does not make the most of the data and thus limits the
power. In contrast, the maternal-fetal genotype incom-
patibility (MFG) test [6] could model nuclear families
with multiple affected siblings. Compared with the
generalized linear models LL-LRT and PO-LRT, it does
require more effort in formulating the likelihood to
implement the MFG test. The MFG test was developed to
detect maternal effect and an interaction effect between
the mother carrying one copy of the disease suscept-
ibility allele and the child carrying no copy under the
assumption of no imprinting.
Unaffected siblings are also genotyped in many genetic
studies. Although unaffected siblings have been incor-
porated to infer the missing parental genotypes in LL-
LRT and PO-LRT [7], they do not directly contribute to
model the relative risks due to genomic imprinting and
maternal effect. LL-LRT, PO-LRT, and MFG tests only
model affected sibling(s) because they all use the data
from retrospective studies. Sampling from a retrospective
study is biased because only families with affected child
(ren) are recruited.
On the other hand, a prospective study like the
Framingham Heart Study (FHS) does not specifically
recruit subjects with a certain disease, thus the originally
recruited cohort could be considered as a random
sample of the general population of healthy people
and patients with any disease. Therefore, a test using data
from a prospective study could utilize both affected and
unaffected siblings by modeling their genotypes and
disease status jointly. Nevertheless, the disease of interest
should not be a rare one; otherwise, the number of
patients in the cohort would be too small to be
sufficiently informative.
In LL-LRT, PO-LRT, and MFG tests, maternal effect is
modeled as a fixed effect because it is assumed that
maternal variant allele(s) has (have) identical effect on
any offspring. This assumption might be invalid if we
consider the cause of maternal effect more carefully.
Maternal effect refers to the phenomenon that the
genotype of a mother is expressed in the phenotype of
her offspring, which is usually attributed to maternally
produced molecules, such as mRNA that are deposited in
the egg cell, and mRNA or antigens that are passed to the
offspring during pregnancy. The latter case could arise
from a biological process called microchimerism. Micro-
chimerism means that two genetically distinct cells, one
being at a low concentration, are present in the same
individual. Microchimerism may be due to transfer of
cells between mother and fetus or between two twins.
Other sources of microchimerism include blood transfu-
sions and organ transplants. Cells transferred from the
mother to the fetus are referred to as maternal micro-
chimerism (MMc). Non-inherited maternal antigen
coding alleles (NIMA) [5,6] within MMc would be
expressed in the offspring and increase his or her
susceptibility to a certain disease. It has been found by
quantitative real-time polymerase chain reaction that
different individuals may have different amounts of
MMc. Therefore, it is likely that the maternal effects
imposed by different mothers are actually heterogeneous
rather than being homogenous as assumed in the
previous studies.
In this study, we will discuss a prospective likelihood
formulation that will take multiple affected and unaf-
fected siblings into consideration. Further, we will treat
maternal effects as random to model heterogeneity. This
method will then be applied to the high blood pressure
(HBP) trait in the FHS.
Methods
Definition of HBP trait in FHS
HBP in an adult is defined as a blood pressure greater
than or equal to 140 mm Hg systolic pressure or greater
than or equal to 90 mm Hg diastolic pressure. High
blood pressure directly increases the risk of coronary
heart disease and stroke, especially when it is present
with other risk factors. In the FHS, systolic pressure and
diastolic pressure of the Original Cohort (the first
generation) and their Offspring Cohort (the second
generation) were measured at four exams, and were
measured once in the Generation 3. Based on the highest
measurements among all available ones, there were
1,036 individuals having high blood pressure and 1,724
individuals having normal blood pressure in the Off-
spring Cohort. In Generation 3, there were 379
individuals having high blood pressure and 3,618
individuals having normal blood pressure. Our analysis
was based on these phenotypic data and the genotypes
of nuclear families. Families with missing parental
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are not informative for imprinting and maternal effects if
both parents’ genotypes are missing.
Moreover, only one nuclear family was selected at
random to be included in the analysis from each three-
generation pedigree. This selection process led to
approximately 300 nuclear families (with the number
of children in each family ranging from 1-8) for each
single-nucleotide polymorphism (SNP).
Prospective likelihood and random effect modeling
Suppose there are N nuclear families. The i
th family has
two parents and ni children, i =1 ,2 ,. . . ,N. We model the
genotypes of all family members and disease statuses of
all children jointly. Let Mi and Fi denote the genotypes of
mother and father in the i
th family.
G
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12 denotes the genotypes of ni children
in the i
th family. Mi, Fi,a n dCi
j could take a value of 0, 1,
or 2, indicating the number of the minor allele(s) at a
SNP carried by the corresponding person, j =1 ,2 ,. . . ,n.
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12 denotes the sibling’s disease status,
with Di
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th child in the i
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being affected, and 0 indicating otherwise.
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We use the logit model to relate the penetrance to the
imprinting effect (part of the b parameters) and the
maternal effect (the g parameters):
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parameter vector
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the logit of phenocopy rate; b1 measures the effect of the
single minor allele inherited from the father; b1 + bim
measures the effect of the single minor allele inherited
from the mother; bim measures the imprinting effect,
with bim < 0 indicating maternal imprinting and bim >0
indicating paternal imprinting; b2 measures the effect of
two copies of the minor allele; g1 and g2 measure the
maternal effect when the mother carries one or two
copies of the minor allele, respectively. Because we
assume that different mothers may impose heteroge-
neous maternal effects, εi measures the deviation of the
effect size from the mean; it also introduces correlation
among the siblings within the same family. Specifically,
εi i sa s s u m e dt of o l l o wN(0, s
2).
The parameters b0, b1, b2, bim, g1, g2,a n ds
2 are estimated
by maximizing the likelihood using the procedure
NLMIXED in SAS.
Selection of SNPs
SNPs that may have a minor allele effect, imprinting
effect, or maternal effect are selected in the first step and
the heterogeneity of maternal effects is detected in the
second step. In the first step, we fit the parsimonious
fixed-effect model without the random component εi
and use the minimum p-value (among the tests for b1 =
0, b2 =0 ,bim =0 ,g1 =0 ,a n dg2 =0 )b e i n g≤ 0.00005 as
the criterion to choose the SNPs. We then screen the
selected SNPs by checking specific parameter con-
straints. The assumption that carrying minor alleles
would increase the disease risk implies that b1 ≥ 0a n d
b1 + bim ≥ 0. Furthermore, two copies of the minor allele
should have an effect at least as large as a single copy,
and thus b2 ≥ max(b1, b1 + bim). Estimates of b1 and b2
being significantly less than zero indicates that labels of
m i n o ra n dm a j o ra l l e l e ss h ould be reversed. SAS does
not allow complex constraints such as b1 + bim ≥ 0a n d
b2 ≥ max(b1, b1 + bim) in its NLMIXED procedure, and
as such we fit a “constraint model” and an “additive
model” to check the intended constraints. In the
“constraint model”, we reparametrize b2 - b1 = ˆ β2
∗
and impose b1 ≥ 0a n d ˆ β2
∗ ≥ 0t oe n s u r et h a tb1 ≥ 0a n d
b2 ≥ 0. In the “additive model”,w ea s s u m ea na d d i t i v e
effect of the two copies of the minor allele, i.e., b2 = b1 +
(b1 + bim), to ensure that b2 ≥ max(b1, b1 + bim). In the
second step, we fit the mixed effect model to the
selected SNPs with significant maternal effect and use
the p-value of testing s = 0 being less than 0.05 and
reduced Akaike information criterion (AIC) value as the
criterion for identifying heterogeneity of maternal
effects.
Results
We scanned 230 k SNPs on chromosomes 1 to 6 and
detected nine SNPs that may be associated with high
blood pressure through minor allele, imprinting, or
m a t e r n a le f f e c t .T h e s en i n eS N P sa r es h o w ni nT a b l e1 .
The p-values for testing b1 =0o rb2 =0b e i n gl e s st h a n
0.05 are shown in boldface, which signifies potential
minor allele effects. For SNPs that have significant minor
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bim = 0 and inferred maternal or paternal imprinting
effect from the sign of ˆ βim .I ft h ep-value for testing
g1 =0o rg2 = 0 is less than 0.05, we further tested for
heterogeneity of the maternal effects in step two. Results
from the second step are shown in Table 2. There are two
rows for each SNPs detected to have potential significant
maternal effect. The first row shows the estimates,
p-values, and AIC of the fixed effect model, while the
s e c o n dr o ws h o w st h o s eo ft h em i x e de f f e c tm o d e l .I ft h e
p-value for testing s = 0 is less than 0.05 and the AIC is
reduced by fitting the mixed effect model, we concluded
that the maternal effect is heterogeneous. Five SNPs were
detected to have various degrees of maternal effects, of
which four appears to be heterogeneous among the
families (Table 2).
To summarize and visualize the result, we categorize the
nine SNPs into a Venn diagram (Figure 1) according to
how the SNPs are associated with high blood pressure.
SNPs listed in the intersecting areas have the correspond-
ing effects shown in the legend simultaneously. The
locations of the nine detected SNPs in human genome
are shown in the first column of Table 1.
Discussion
In the Genetic Association Studies of Complex Diseases
and Disorders section of the Genome Browser, we found
that the association between the nine detected SNPs and
blood pressure has been established either in human or
in rat (see the third column of Table 1). This finding
confirms the effectiveness of our method in detecting
genetic association. Although the associations of five of
these nine SNPs have been reported in human studies,
we have found the associations of four additional SNPs
in humans, rs1979148, rs17476063, rs13076104, and
rs9866277, which were only reported in rat before.
Furthermore, there is no previous report of imprinting or
maternal effect for any of the nine detected SNPs,
whereas our model detected potential imprinting effects
for three and maternal effects for five of the SNPs.
Finally, we note that, in our current formulation, siblings
sharing the same mother have the same maternal effect
component, and so it would be interesting to consider
hierarchical modelling to further delineate maternal
effect heterogeneity among offspring of the same
mother. However, random inheritance of the minor
allele from mother and father would impose different
imprinting component on them, which helps to separate
Table 1: Parameter estimates and p-values of the fixed effect model in the first step
Location SNP Association with BP ˆ β1and p-value ˆ β2 and p-value ˆ β2
∗ and p-value ˆ γ1and p-value ˆ γ 2 and p-value
Chr2 p22.3 rs1979148 Rat 0.406 0.3365 -3.579 0.2899 -1.445 0.0200 1.648 0.0000 1.769 0.0517
Chr1 q41 rs17476063 Rat 0.661 0.0883 -0.650 0.3358 -2.201 0.0015 1.644 0.0000 0.441 0.7048
Chr4 q26 rs1459543 Human 1.957 0.0000
a 1.296 0.0146 -1.586 0.0109 0.346 0.3935 0.100 0.8677
Chr1 p36.22 rs6688233 Human, Rat 1.573 0.0000 0.234 0.7368 -1.609 0.0112 0.377 0.3854 0.747 0.3410
Chr6 q24.1 rs4386830 Human 1.046 0.0178 -1.018 0.0809 -2.414 0.0003 1.741 0.0001 3.031 0.0000
Chr3 p14.1 rs13076104 Rat 1.323 0.0000 -0.008 0.9910 -1.154 0.0820 0.141 0.7209 0.487 0.5428
Chr2 q24.1 rs10209732 Human, Rat 0.469 0.3301 -1.535 0.1515 -1.089 0.1160 1.632 0.0000 1.746 0.0619
Chr3 q26.1 rs2030350 Human, Rat -0.260 0.5752 -0.902 0.1503 -1.856 0.0202 1.422 0.0000 0.726 0.5396
Chr3 p12.1 rs9866277 Rat 1.442 0.0000 0.100 0.9367 -0.488 0.5423 -0.565 0.3501 -0.361 0.7332
aBold font under ˆ β1, ˆ β2 , ˆ γ1,a n d ˆ γ 2 indicates p-value ≤ 0.05. Bold font under ˆ β2
∗ indicates p-value ≤ 0.05 and at least one p-value ≤ 0.05 for
testing whether b1 =0a n db2 =0 .
Table 2: Parameter estimates, p-values, and AICs of the fixed and mixed effect models in the second step
Location SNP ˆ β1and p-value ˆ β2 and p-value ˆ β2
∗ and p-value ˆ γ1and p-value ˆ γ 2 and p-value ˆ σ and p-value AIC
Chr2 p22.3 rs1979148 0.406 0.3365 -3.579 0.2899 -1.445 0.0200 1.648 0.0000 1.769 0.0517 —— 1548.1
0.807 0.3500 -2.256 0.5740 -2.469 0.0328 1.886 0.0381 2.273 0.3364 6.771 0.0000
a 1523.6
Chr1 q41 rs17476063 0.661 0.0883 -0.650 0.3358 -2.201 0.0015 1.644 0.0000 0.441 0.7048 —— 1797.4
0.630 0.4079 -2.637 0.2000 -4.562 0.0035 2.041 0.0212 2.125 0.5012 6.775 0.0001 1782.0
Chr6 q24.1 rs4386830 1.046 0.0178 -1.018 0.0809 -2.414 0.0003 1.741 0.0001 3.031 0.0000 —— 1847.1
1.950 0.0936 -4.746 0.0027 -3.739 0.0198 3.017 0.0339 5.217 0.0116 8.388 0.0000 1822.6
Chr2 p24.1 rs10209732 0.469 0.3301 -1.535 0.1515 -1.089 0.1160 1.632 0.0000 1.746 0.0619 —— 1655.1
0.361 0.5324 -1.589 0.1841 -1.204 0.1482 1.834 0.0005 2.038 0.0902 1.596 0.0164 1653.3
Chr3 q26.1 rs2030350 -0.260 0.5752 -0.902 0.1503 -1.856 0.0202 1.422 0.0000 0.726 0.5396 —— 1704.6
0.003 0.9957 -1.443 0.1047 -2.709 0.0276 1.840 0.0033 1.439 0.3453 1.925 0.0798 1700.4
aBold font indicates p-value ≤ 0.05 for testing whether s =0 .
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we found that our method could detect maternal and
imprinting effects simultaneously with reasonable power
via simulation.
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